Autore	Bender David A
Edizione	[3rd ed.]
Pubbl/distr/stampa	Hoboken, : Wiley, 2012
Descrizione fisica	1 online resource (480 p.)
Disciplina	572.65 572/.65
Soggetto topico	Amino acids - Metabolism Amino Acids, Peptides, and Proteins Metabolic Phenomena Drugs Metabolism Amino Acids
ISBN	1-118-35818-X 1-283-54246-3 9786613854919 1-118-35817-1 1-118-35751-5 1-118-35819-8
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	1.4.1 Purine synthesis 1.4.1.1 Phosphoribosyl pyrophosphate (PRPP) synthetase; 1.4.1.2 PRPP amidotransferase; 1.4.2 Purine catabolism and salvage; 1.4.2.1 Adenosine deaminase deficiency - severe combined immune deficiency; 1.4.2.2 Gout and hyperuricaemia; 1.4.2.3 HGPRT deficiency - the Lesch-Nyhan syndrome; 1.4.3 Pyrimidine synthesis; 1.4.3.1 Orotic aciduria; 1.4.4 Pyrimidine catabolism and salvage; 1.5 Deamination of amino acids; 1.5.1 Amino acid oxidases; 1.5.2 Amine oxidases; 1.5.3 Glutamate and alanine dehydrogenases; 1.5.4 Non-oxidative deamination of amino acids 1.5.5 Glutaminase and asparaginase 1.6 Excretion of nitrogenous waste; 1.6.1 Uricotelic and purinotelic species; 1.6.2 Ureotelic species; 1.6.2.1 Urea synthesis; 1.6.2.2 Inborn errors of metabolism affecting the urea synthesis cycle; 1.6.2.3 Entero-hepatic circulation of urea; 1.6.2.4 Canavanine; 1.7 Other nitrogenous compounds in human urine; 1.7.1 Aminoacidurias; Further reading; 2: Nitrogen Balance and Protein Turnover - Protein and Amino Acids in Human Nutrition; 2.1 Nitrogen balance and protein requirements; 2.1.1 Protein digestion and absorption 2.1.2 Protein digestibility and unavailable amino acids in dietary proteins 2.1.3 Obligatory nitrogen losses; 2.1.4 Dynamic equilibrium and tissue protein turnover; 2.1.5 Tissue protein catabolism; 2.1.5.1 Lysosomal autophagy; 2.1.5.2 Ubiquitin and the proteasome; 2.1.5.3 Active site proteolysis of apo-enzymes; 2.1.6 Whole body protein turnover; 2.1.6.1 The constant infusion, labelled precursor method; 2.1.6.2 The constant infusion, labelled end product method; 2.1.6.3 Rates of whole-body protein turnover; 2.1.6.4 The catabolic drive and amino acid oxidation 2.1.6.5 The energy cost of protein turnover
Record Nr.	UNINA-9910139693803321

Pubbl/distr/stampa	[Place of publication not identified], : Wiley VCH, 2005
Soggetto topico	Amyloidosis Amyloid Protein Structure, Secondary Proteins Protein Conformation Multiprotein Complexes Proteostasis Deficiencies Molecular Conformation Macromolecular Substances Amino Acids, Peptides, and Proteins Metabolic Diseases Nutritional and Metabolic Diseases Chemicals and Drugs Molecular Structure Biochemical Phenomena Diseases Chemical Phenomena Phenomena and Processes Animal Biochemistry Human Anatomy & Physiology Health & Biological Sciences
ISBN	3-527-61934-8
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Record Nr.	UNINA-9910144007403321

Autore	Mozzarelli Andrea
Pubbl/distr/stampa	Hoboken, : Wiley, 2011
Descrizione fisica	1 online resource (476 p.)
Disciplina	615.8/36 615.836
Altri autori (Persone)	BettatiStefano
Soggetto topico	Hemoglobins - therapeutic use Hemoglobins -- therapeutic use Nitric oxide - Physiological effect Nitric oxide -- Physiological effect Oxigen - Physiological effect Oxigen -- Physiological effect Oxygen - blood Oxygen -- blood Oxygen Consumption Oxygen Inhalation Therapy - methods Oxygen Inhalation Therapy -- methods Oxygen therapy SCIENCE / Life Sciences / Biochemistry Oxygen therapy - Physiological effect Oxygen - Physiological effect Nitric oxide Metabolic Phenomena Respiratory Therapy Investigative Techniques Body Fluids Globins Chalcogens Blood Proteins Gases Therapeutics Fluids and Secretions Elements Hemeproteins Inorganic Chemicals Proteins Amino Acids, Peptides, and Proteins Anatomy Oxygen Blood Hemoglobins Methods Oxygen Inhalation Therapy Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology
ISBN	1-283-17785-4 9786613177858 1-119-97542-5 1-119-97543-3
Classificazione	SCI007000
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	Chemistry and Biochemistry of Oxygen Therapeutics; Contents; List of Contributors; Preface; 1. Introduction; References; Part I. Oxygen: Chemistry, Biochemistry, Physiology and Toxicity; 2. Hemoglobin Reactivity and Regulation; 2.1 Introduction; 2.2 Oxygen Loading and Transport; 2.3 NO Reactivity with Hb; 2.4 Hb Oxidation; 2.5 Nitrite Reactivity with Hb; 2.6 Amino-acid Determinants of Hb Reactivity: Natural and Engineered Hbs; 2.6.1 Modulation of Oxygen Affinity and Cooperativity; 2.6.2 NO Reactivity and Oxidation; 2.7 Conclusion; Acknowledgments; References 3. The Major Physiological Control Mechanisms of Blood Flow and Oxygen Delivery3.1 Introduction; 3.2 Autoregulation of Blood Flow to Changes in Perfusion Pressure; 3.3 Metabolic Regulation of Blood Flow; 3.4 O2 Transport; 3.5 O2 Delivery; 3.6 Endothelial Control of Vasomotor Tone; 3.7 Effect of Cell-free Hb on Endothelial Function; 3.8 Hypoxic Hypoxia; 3.9 Carbon Monoxide Hypoxia; 3.10 Anemia; 3.11 Conclusion; References; 4. The Main Players: Hemoglobin and Myoglobin; Nitric Oxide and Oxygen; 4.1 Introduction; 4.2 Role of Mammalian Mb in O2 Homeostasis 4.3 WhatLfs Missing in the Mb Knockout Mouse4.4 Evolutionary Origins of Mb and the Nitrogen Cycle; 4.5 Human Hb: Evolved Sensor of pO2 and Redox; 4.6 Broad Reactivity and Influence of NO: Lessons from the Microcosm Hb; 4.7 Some Fish Demonstrate a Fundamental "Need" for Hb-dependent NO Cycling, as in Humans; 4.8 Reactions of NO with Hb that Preserve NO Bioactivity; 4.9 Mammalian RBC/Hb.NO Interactions; 4.10 A Mutant Mouse Challenges the SNO-Hb Hypothesis, but does not Overthrow it; 4.11 Signaling by Hb-derived SNO: A Metabolically Responsive, Regulated Pathway 4.12 Signaling by Hb-derived SNO: Pathway Complexity Revealed by Multiple Defects in Disease States4.13 Therapeutic Implications of the Hb.NO Signaling System; 4.14 HBOCs, NO, and SNO; 4.15 Other Gaseous Hb Ligands of Potential Therapeutic Significance; 4.16 NO-related Enzymatic Activities of Hb: Reconciling Nitrite Reductase and SNO Synthase Functions; 4.17 Measuring Biologically Relevant Hb.NO Adducts; 4.18 Conclusion; Acknowledgments; References; 5. The Role of Reactive Oxygen and Nitrogen Species in Ischemia/Reperfusion Injury; 5.1 Introduction 5.2 Redox System and Free Radicals in Biological Systems5.3 Pathophysiology of Ischemia/Reperfusion Injury; 5.3.1 Cell Death; 5.3.2 The Inflammatory Response; 5.4 Protection Against I/R Injury; 5.4.1 Ischemic Pre- and Post-conditioning; 5.4.2 Pharmacological Conditioning; 5.4.2.1 The Protective Role of ROS and Antioxidants; 5.4.2.2 The Protective Role of NO; 5.4.2.3 NO-based Therapies for I/R Injury; 5.5 Conclusion; Acknowledgments; References; Part II. Medical Needs for Oxygen Supply; 6. Acute Traumatic Hemorrhage and Anemia; 6.1 Introduction; 6.2 Blood Transfusion in Trauma 6.2.1 Massive Transfusion
Record Nr.	UNINA-9910139631203321

Autore	Levitan Irena
Pubbl/distr/stampa	Hoboken, : Wiley, 2012
Descrizione fisica	1 online resource (324 p.)
Disciplina	572.5795 612.1/2 612.12
Altri autori (Persone)	BarrantesFrancisco
Soggetto topico	Cholesterol - metabolism Cholesterol -- metabolism Ion Channels - metabolism Ion Channels -- metabolism Membrane Proteins - metabolism Membrane Proteins -- metabolism Cholesterol - Metabolism Ion channels - Metabolism Membrane proteins - Metabolism Proteins Membrane Glycoproteins Sterols Membrane Transport Proteins Metabolic Phenomena Cholestenes Amino Acids, Peptides, and Proteins Carrier Proteins Cholestanes Membrane Lipids Lipids Steroids Drugs Polycyclic Compounds Cholesterol Ion Channels Metabolism Membrane Proteins Human Anatomy & Physiology Health & Biological Sciences Animal Biochemistry
ISBN	1-280-87984-X 9786613721150 1-118-34230-5 1-118-34231-3 1-118-34228-3
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	CHOLESTEROL REGULATION OF ION CHANNELS AND RECEPTORS; CONTENTS; FOREWORD; PREFACE; CONTRIBUTORS; I CHOLESTEROL REGULATION OF MEMBRANE PROPERTIES; 1 CHOLESTEROL TRAFFICKING AND DISTRIBUTION BETWEEN CELLULAR MEMBRANES; 1.1 CHOLESTEROL-AN ESSENTIAL LIPID FOR NORMAL CELL FUNCTION; 1.2 CHOLESTEROL METABOLISM, SENSING, AND DISTRIBUTION BETWEEN CELLULAR MEMBRANES; 1.3 HOW DOES CHOLESTEROL ENTER MAMMALIAN CELLS?; 1.4 VESICULAR CHOLESTEROL TRAFFICKING ALONG THE ENDOCYTIC AND SECRETORY PATHWAY; 1.5 NONVESICULAR CHOLESTEROL TRANSPORT; 1.6 CHOLESTEROL EFFLUX FROM CELLS; REFERENCES 2 CHOLESTEROL REGULATION OF MEMBRANE PROTEIN FUNCTION BY CHANGES IN BILAYER PHYSICAL PROPERTIES-AN ENERGETIC PERSPECTIVE2.1 INTRODUCTION; 2.2 CHOLESTEROL REGULATION OF MEMBRANE PROTEINS: POSSIBLE MECHANISMS; 2.3 PROTEIN REGULATION BY CHOLESTEROL-INDUCED CHANGES IN BILAYER PHYSICAL PROPERTIES; 2.4 CHOLESTEROL-INDUCED CHANGES IN DGIII bilayer - QUANTITATIVE ESTIMATES; 2.5 METHODS FOR IDENTIFYING PROTEIN REGULATION BY CHANGES IN BILAYER PHYSICAL PROPERTIES; 2.6 CHOLESTEROL REGULATION OF MEMBRANE PROTEINS IN LIVING CELLS 2.7 PHYSIOLOGICAL ROLE OF CHOLESTEROL-INDUCED CHANGES IN BILAYER PHYSICAL PROPERTIES2.8 CONCLUSION; REFERENCES; II CHOLESTEROL REGULATION OF ION CHANNELS; 3 INSIGHTS INTO STRUCTURAL DETERMINANTS OF CHOLESTEROL SENSITIVITY OF KIR CHANNELS; 3.1 INTRODUCTION; 3.2 CHOLESTEROL SUPPRESSES Kir2 ACTIVITY IN VITRO AND IN VIVO; 3.3 EVIDENCE FOR SPECIFIC STEROL-PROTEIN INTERACTIONS IN THE REGULATION OF Kir CHANNELS; 3.4 STRUCTURAL DETERMINANTS OF CHOLESTEROL SENSITIVITY OF Kir2 CHANNELS; 3.5 PHYSIOLOGICAL IMPACT OF CHOLESTEROL-INDUCED SUPPRESSION OF KIR2 CHANNELS 3.6 CONCLUDING REMARKS AND FUTURE DIRECTIONSACKNOWLEDGMENTS; REFERENCES; 4 ROLE OF LIPID RAFTS IN THE REGULATION OF STORE-OPERATED CA2+ CHANNELS; 4.1 INTRODUCTION; 4.2 MOLECULAR COMPONENTS OF SOCE; 4.3 LIPID RAFT DOMAINS AND CAVEOLAE; 4.4 THE ROLE OF LIPID RAFT DOMAINS IN THE REGULATION OF TRPC1; 4.5 MOLECULAR COMPLEXITY IN THE REGULATION OF SOCE; 4.6 CONCLUSIONS; REFERENCES; 5 CHOLESTEROL REGULATION OF CARDIAC ION CHANNELS; 5.1 INTRODUCTION; 5.2 EFFECT OF CHOLESTEROL ON CARDIAC EXCITABILITY; 5.3 MECHANISMS OF CHOLESTEROL EFFECTS ON ION CHANNELS 5.4 CHOLESTEROL AS A TARGET FOR THERAPEUTIC AGENTSREFERENCES; 6 DIFFERENTIAL CONTRIBUTION OF BK SUBUNITS TO NONGENOMIC REGULATION OF CHANNEL FUNCTION BY STEROIDS; 6.1 BK CHANNELS AND STEROIDS; 6.2 CONCLUSIONS; ACKNOWLEDGMENTS; REFERENCES; 7 REGULATION OF K+ CHANNELS BY CHOLESTEROL-RICH MEMBRANE DOMAINS IN THE IMMUNE SYSTEM; 7.1 POTASSIUM CHANNELS IN THE IMMUNE SYSTEM; 7.2 REGULATION OF POTASSIUM CHANNELS BY MEMBRANE CHOLESTEROL AND LIPID RAFT MICRODOMAINS; 7.3 LOCALIZATION OF MAJOR VOLTAGE-DEPENDENT Kv1.3 AND Kv1.5 CHANNELS IN CHOLESTEROL-RICH MEMBRANE MICRODOMAINS IN LEUKOCYTES 7.4 MECHANISMS OF ION CHANNEL REGULATION: THE IMMUNOLOGICAL SYNAPSE
Record Nr.	UNINA-9910141264403321